基本资料 投资组合 财务数据 基金公告
嘉实标普生物科技精选行业ETF(QDII)(159502) |
净值：
1.3165
|
日增长率：
-0.11%
|
累计净值：1.3165 | 2025-12-25 |
|
|
||||
| 股票代码 | 股票简称 | 持股数量(股) | 持股市值(元) | 占基金净值比(%) |
| CRSP | CRISPR Therapeutics AG | 74,356.00 | 34,241,492.32 | 2.25 |
| EXEL | 伊克力西斯 | 102,894.00 | 30,194,979.99 | 1.98 |
| ABBV | 艾伯维 | 18,329.00 | 30,155,007.72 | 1.98 |
| MDGL | Madrigal Pharmaceuticals Inc | 9,019.00 | 29,392,998.83 | 1.93 |
| MRNA | Moderna Inc | 159,568.00 | 29,286,323.25 | 1.92 |
| UTHR | 联合治疗 | 9,783.00 | 29,140,589.38 | 1.91 |
| RVMD | Revolution Medicines Inc | 86,663.00 | 28,757,110.30 | 1.89 |
| IONS | Ionis Pharmaceuticals Inc | 60,611.00 | 28,174,526.95 | 1.85 |
| AMGN | 安进 | 13,928.00 | 27,928,037.01 | 1.83 |
| REGN | 再生元制药 | 6,979.00 | 27,882,567.00 | 1.83 |
| 报告期 | 股票占净比(%) | 债券占净比(%) | 现金占净比(%) | 净资产(元) |
| 2025-09-30 | 99.38 | - | 0.69 | 1,523,149,285.27 |
| 2025-06-30 | 99.24 | - | 0.81 | 1,231,192,496.86 |
| 2025-03-31 | 99.48 | - | 2.07 | 1,073,213,261.21 |
| 2024-12-31 | 99.49 | - | 0.59 | 1,062,564,960.47 |
| 2024-09-30 | 99.42 | - | 0.87 | 1,013,082,685.62 |
微信公众号
证券之星APP
